/PRNewswire/ Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS.
Chordant Onboards Beam Connectivity onto Convex - The Global Mobility Data Exchange Service
Share Article
Chordant onboards Beam Connectivity onto their global mobility data exchange service following their successful selection into the Zenzic CAM Scale-Up programme. I’m excited to see how this collaboration will drive the development of connected and self-driving mobility services, says Mika Rasingkangas, Chordant s President. LONDON (PRWEB) February 01, 2021 Chordant today announced that it onboarded Beam Connectivity onto Convex, the global mobility data exchange, following their successful selection into the Zenzic CAM Scale-Up programme.
Convex enables subscribers like Beam Connectivity to share, transform and integrate their dynamic vehicle and mobility data with 3rd party services and systems. Sitting at the intersection between Connected and Autonomous Vehicles, Intelligent Transport Infrastructur
Post money valuation: $25 million
Biggest funding round of 2020: $1 million raised in a convertible note deal. The company said it is looking to raise Series A funding this year.
Total raised to date: $2 million
What the company does: Abstrax is a California-based research firm that creates terpene profiles active chemicals in the cannabis plant for use in isolates, vaporizers, or even as food and beverage additives.
Why investors like the company:
Panther Opportunity Fund s principal
Jordan Tritt says that Abstrax is pioneering consumer sensorial experiences in the cannabis industry. Their cutting edge research, development and formulations have the potential to revolutionize various consumer packaged goods products, he continued.
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Helix Technologies, Inc. Merger
WILMINGTON, Del., Jan. 06, 2021 (GLOBE NEWSWIRE)
Rigrodsky & Long, P.A. announces that it is investigating Helix Technologies, Inc. (“Helix”) (OTC: HLIX) regarding possible breaches of fiduciary duties and other violations of law related to Helix’s agreement to be acquired by Medical Outcomes Research Analytics Inc. and Forian Inc. (“Forian”). Under the terms of the agreement, Helix’s shareholders will receive 0.05 shares of Forian common stock per share.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-helix-technologies-inc.
You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected]
/PRNewswire/ If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this.